SCHEMBL324660

SCHEMBL324660

O=COCc1nc2ccccc2s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.59
NPC1 O15118 6/20 0.59
RAB9A P51151 6/20 0.59
L3MBTL1 Q9Y468 4/20 0.59
MAPK1 P28482 1/20 0.59
CYP1A2 P05177 2/20 0.59
CYP2C19 P33261 2/20 0.59
KMT2A Q03164 2/20 0.57
UBE2T Q9NPD8 1/20 0.54
ASIC3 Q9UHC3 1/20 0.54
MAPT P10636 4/20 0.54
HPGD P15428 2/20 0.54
HSD17B10 Q99714 1/20 0.54
PKM P14618 1/20 0.54
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
TSHR P16473 1/20 0.50
LMNA P02545 1/20 0.50
ALOX5 P09917 1/20 0.48
EPHX2 P34913 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27706614 0.84 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9AL3MBTL1MAPK1
SCHEMBL28320559 0.79 NPC1 (0.56) SMN1; SMN2NPC1RAB9AL3MBTL1MAPK1
SCHEMBL1521239 0.79 NPC1 (0.67) SMN1; SMN2NPC1RAB9AL3MBTL1MAPK1
SCHEMBL27883013 0.77 NPC1 (0.65) SMN1; SMN2NPC1RAB9AL3MBTL1MAPK1
SCHEMBL660014 0.77 MAPT (0.67) SMN1; SMN2NPC1RAB9AL3MBTL1MAPK1
SCHEMBL620659 0.77 UBE2T (0.59) SMN1; SMN2NPC1RAB9AL3MBTL1MAPK1
SCHEMBL26095926 0.77 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AL3MBTL1MAPK1
SCHEMBL6964094 0.76 NPC1 (0.71) SMN1; SMN2NPC1RAB9AL3MBTL1MAPK1
SCHEMBL28031301 0.75 DYRK1A (0.46)
2-(Phenoxymethyl)Benzothiazole SCHEMBL2245843 0.75 NPC1 (1.00) SMN1; SMN2NPC1RAB9AL3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110292948-A Imidazoles villaumite containing single imines functionalization is preparing the application in aromatic heterocycle formic ether compounds as catalyst 苏州大学 2019-10-01 CN disclosed
CN-106565623-B Method for synthesizing aromatic heterocyclic formate compound 苏州大学 2019-07-16 CN disclosed
EP-2590944-A1 1-PHENYL-SUBSTITUTED HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS Actelion Pharmaceuticals Ltd. (CH) 2013-05-15 EP disclosed
WO-2012004722-A1 1-PHENYL-SUBSTITUTED HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD (CH) 2012-01-12 WO disclosed
CN-1694704-A Use of (1H-benzimidazole-2-yl)-(piperazineyl)- ketaderavitive and correlative compound used as histamine H4 receptor antagonist for the treatment of allergy and asthma JANSSEN PHARMACEUTICA NV (BE) 2005-11-09 CN disclosed